*Some Market data delayed by 15 mins.

Insmed, Inc.

Symbol: INSM (NASDAQ)
146.40 ▲ (1.66%) 2.393

Company Description:
Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the United States for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. It is also developing Brensocatib, an oral reversible dipeptidyl peptidase 1 inhibitor for bronchiectasis and other neutrophil-mediated diseases, and Treprostinil Palmitil Inhalation Powder, an inhaled treprostinil prodrug for pulmonary hypertension linked to interstitial lung disease and pulmonary arterial hypertension.

Key Stats
  • Today's Open: $144.7
  • Today's High: $146.5
  • Today's Low: $142.055
  • Today's Volume: 425.04K
  • Yesterday Close: $144.01
  • Yesterday High: $145.41
  • Yesterday Low: $141
  • Yesterday Volume: 2.65M
  • Last Min Volume: 1.56K
  • Last Min High: $146.5
  • Last Min Low: $146.443
  • Last Min VWAP: $146.4719
Company Profile
  • Name: Insmed, Inc.
  • Website: https://www.insmed.com
  • Listed Date: 2000-06-01
  • Location: BRIDGEWATER, NJ
  • Market Status: Active
  • CIK Number: 0001104506
  • SIC Code: 2834
  • SIC description: PHARMACEUTICAL PREPARATIONS
  • Market Cap: $30.44B
  • Round Lot: 100
  • Outstanding Shares: 211.37M
  • Asset Type: CS
RECENT FILINGS FOR INSM
Filing Date Filing Type Format
2025-09-15 4 View
2025-09-15 4 View
2025-09-12 144 View
2025-09-12 144 View
2025-09-05 4 View
2025-09-04 4 View
2025-09-04 4 View
2025-09-04 SCHEDULE 13G/A View
2025-09-02 144 View
2025-09-02 144 View
2025-08-21 4 View
2025-08-21 4 View
2025-08-20 4 View
2025-08-20 144 View
2025-08-19 144 View
2025-08-18 144 View
2025-08-18 4 View
2025-08-14 4 View
2025-08-14 144 View
2025-08-14 SCHEDULE 13G/A View
Latest News on INSM

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.